COVID-19 Community Research Partnership FAQs

Thank you for your interest in learning more about this study. Please read the following information to ensure that you would like to participate. Then click the link below to get started.

Researchers at MedStar Health are partnering with patients to better understand the spread of COVID-19. Study participants will answer short online questions (that take less than 30 seconds a day) over several months about possible exposures, symptoms and health care visits. Some volunteers may be asked to complete an in-home test kit for antibodies to COVID-19.

This study is open to everyone in our community, whether or not you have received care at MedStar Health.

I would like to enroll in this study.

Contact Information

Contact us to obtain more information about our research programs.

Search Principal Investigators

If you would like to learn more about MedStar's researchers and scientists, please visit our Principal Investigator search portal.

MedStar Health Awarded Grant to Implement and Evaluate Innovative Sepsis Clinical Decision Support

Through the Diagnostic Quality Improvement Seed Grant Program from the Society to Improve Diagnosis in Medicine, the MedStar Health research team will leverage existing electronic health data to help patient outcomes in cases of sepsis.

Hyattsville, MD — MedStar Health National Center for Human Factors in Healthcare was one of 17 organizations awarded a grant by The Society to Improve Diagnosis in Medicine (SIDM) as part of its Diagnostic Quality Improvement (DxQI) Seed Grant Program to improve the quality, accuracy, and timeliness of diagnoses. SIDM awarded MedStar Health $50,000 to support testing an intervention designed to improve diagnosis of sepsis of patients within our healthcare system.

MedStar Health will use this grant to address sepsis, the most common cause of in-hospital death and the most expensive in-patient cost. Many septic patients are not diagnosed at an early stage when aggressive treatment has the potential to reverse the course of infection. Led by principal investigator Kristen Miller, DrPH, MSPH, CPPS, Scientific Director MedStar Health National Center for Human Factors in Healthcare; Associate Professor of Emergency Medicine, Georgetown University School of Medicine, the program will launch and evaluate a new sepsis-specific clinical decision support tool that uses a validated sepsis staging model to provide earlier and more accurate characterization of sepsis patients. The research will leverage existing electronic health record data in a meaningful way, while reducing clinical burden and supporting improved workflow with a user-centered design approach with enhanced visual displays.

Inaccurate and delayed diagnoses are the most common, catastrophic, and costly of medical errors according to previous research. It is estimated that 12 million adults in the United States experience a diagnostic error every year in outpatient settings alone, and diagnosis failures result in as many as 80,000 premature deaths every year in U.S. hospitals.

 “We are eager to work towards improving diagnosis of sepsis,” said Dr. Miller. “Diagnostic error is a significant problem that the healthcare community needs to address, specifically diagnosis of sepsis which continues to increase annually despite increased awareness. We are proud to be part of a cohort developing specific strategies to improve the accuracy and timeliness of diagnosis. This is just one of many continuing efforts to improve patient care at MedStar Health.”

This research will build on the previous work by the Center, focused on more effectively displaying clinical data to clinicians within the electronic health record to improve sepsis diagnosis. This early work, funded through a R01 from the National Library of Medicine (NLM) developed graphical model displays of two popular sepsis scoring systems.

The SIDM DxQI program is unique. Grantees will identify and implement small, practical tests of change, and begin building evidence supporting interventions. If replicated and spread across other hospitals and health systems, these interventions have the potential to improve diagnosis.

“There are very few proven real-world solutions to minimize the harm diagnostic errors can cause,” said Gerard M. Castro, PhD, MPH, PMP, Director of Quality Improvement, SIDM. “The DxQI grants awarded through the program are a first step in learning what best practices we can build into the diagnostic process to ensure that patients receive a diagnosis that is accurate, determined in a timely manner, and effectively communicated.”

DxQI Seed Grant program will help clinicians, hospitals and health systems take specific steps to reduce diagnostic errors by building an evidence base of effective interventions. Once tested, SIDM will create a clearinghouse of the interventions and be a catalyst for the adoption of effective practices by other organizations across the country. The DxQI Seed Grant Program is an initiative of the Society to Improve Diagnosis in Medicine with support from the Gordon and Betty Moore Foundation.

 

###

About MedStar Human Factors
The MedStar Health National Center for Human Factors in Healthcare occupies a unique position in the United States as the largest human factors program embedded within a healthcare system. It brings together human factors scientists, systems safety engineers, health services researchers, clinicians, and other experts to create a safer and more efficient healthcare environment through four core services in research, usability, safety advisement, and education. The Center is part of the MedStar Health Research Institute and is also affiliated with the MedStar Institute for Innovation and MedStar Institute for Quality and Safety. MedStar Health, the parent organization, is the largest not-for-profit healthcare provider in the Maryland and Washington, D.C., region, with 10 hospitals and an extensive ambulatory services network, and is the medical education and clinical partner of Georgetown University.

About MedStar Health Research Institute
MedStar Health Research Institute is the research arm of MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region. MHRI provides scientific, administrative and regulatory support for research programs throughout the MedStar Health system. MHRI’s expertise includes translational research into disease prevention, diagnosis and treatment. These programs complement the key clinical services and teaching programs in the 10 MedStar hospitals and other MedStar entities. For more information, visit www.MedStarResearch.org.

About MedStar Health
At MedStar Health, we use the best of our minds and the best of our hearts to serve our patients, those who care for them, and our communities. Our 30,000 associates and 4,700 affiliated physicians are committed to living this promise through our core SPIRIT values—Service, Patient first, Integrity, Respect, Innovation, and Teamwork—across our more than 300 locations including 10 hospitals, ambulatory, and urgent care centers. As the medical education and clinical partner of Georgetown University, MedStar Health is training future physician leaders to care for the whole person and is advancing care through the MedStar Health Research Institute. From our telemedicine and urgent care services to the region’s largest home health agency, we’re committed to providing high-quality health care that’s also easy and convenient for our patients. At MedStar Health—It’s how we treat people. Learn more at MedStarHealth.org.

About the Society to Improve Diagnosis in Medicine
The Society to Improve Diagnosis in Medicine catalyzes and leads change to improve diagnosis and eliminate harm from diagnostic error. We work in partnership with patients, their families, the healthcare community and every interested stakeholder. SIDM is the only organization focused solely on the problem of diagnostic error and improving the accuracy and timeliness of diagnosis. In 2015, SIDM established the Coalition to Improve Diagnosis to increase awareness and actions that improve diagnosis. Members of the Coalition represent hundreds of thousands of healthcare providers and patients—and the leading health organizations and government agencies involved in patient care. Together, we work to find solutions that enhance diagnostic safety and quality, reduce harm, and ultimately, ensure better health outcomes for patients. Visit www.ImproveDiagnosis.org to learn more.

Media Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]






Asociación de investigación comunitaria de COVID-19

Gracias por su interés en aprender más sobre este estudio. Por favor, lea la siguiente información para asegurarse de que desea participar. Luego, haga clic en el siguiente enlace para empezar.

Los investigadores de MedStar Health se están asociando con los pacientes para comprender mejor la propagación del COVID-19. Los participantes del estudio responderán a breves preguntas en línea (que tarda menos de 30 segundos al día) durante varios meses sobre posibles exposiciones, síntomas y visitas de atención médica. A algunos voluntarios se les puede pedir que completen un kit de prueba casera para detectar anticuerpos contra COVID-19.

Cualquier persona mayor de 18 años puede participar en este estudio. No es necesario que tenga síntomas o COVID-19.

Me gustaria inscribirme en este estudio.

Las preguntas sobre este estudio de investigación pueden ser respondidas llamando al 800-808-5759 o enviando un correo electrónico a la Asociación de investigación comunitaria de COVID-19 a [email protected].

Los estudios de investigación están diseñados para obtener conocimientos científicos que puedan ayudar a las personas en el futuro.

Por favor, tómese su tiempo para decidir si desea participar o no en este estudio de investigación. También puede discutir este estudio y su decisión de participar con sus amigos y familiares. Si tiene preguntas sobre el estudio, llame al 800-808-5759 o envié un correo electrónico a la Asociación de investigación comunitaria de COVID-19 a [email protected].

Vea los datos actualizados de los participantes de la Asociación de investigación comunitaria de COVID-19.

Cualquier persona mayor de 18 años puede participar en este estudio. No es necesario que tenga síntomas o COVID-19.

Primero debe leer el consentimiento de informacion y proporcionará su firma electrónica.

El consentimiento de informacion es importante porque:

  • Describe el estudio
  • Explica por qué se está realizando el estudio
  • Describe lo que se espera de usted
  • Describe los riesgos y beneficios de participar
  • Explica cómo ponerse en contacto con el equipo del estudio si tiene alguna pregunta

Si usted lee el consentimiento informado y decide que no quiere participar en el estudio, está bien. Por favor, no firme el formulario de consentimiento si no quiere participar.

Como usted sabe, la pandemia del COVID-19 es una emergencia mundial de salud pública.

Al estudiar quién ha sido expuesto(a) y posiblemente infectado(a), identificar el momento y las circunstancias de la exposición, y dónde los patrones de infección del COVID-19 están avanzando, los investigadores pueden ayudar a la comunidad médica a entender mejor la pandemia y desarrollar estrategias y tratamientos para contenerla y posiblemente eliminarla.

El objetivo de este estudio es recopilar información sobre las exposiciones a COVID-19 en la comunidad, los síntomas y las visitas de atención médica debidas a la enfermedad. Si usted es del personal de salud, el estudio recopilará información sobre el uso que haga de su equipo de protección personal.

La participación no tiene costo alguno.

La información recopilada sobre usted es solo para fines de investigación. Esta información no se utilizará para guiar su atención médica. Su medico o proveedor de atención médica no tendrá acceso a esta información.

El estudio de investigación no puede proporcionar atención médica o pruebas de COVID-19 si usted se enferma. Los cuestionarios y las pruebas caseras son solo para fines de investigación.

Después de completar el consentimiento informado en línea, se le pedirá que complete un breve cuestionario de inscripción.

Recibirá un correo electrónico con un enlace para completar un formulario de registro en línea. El formulario puede ser completado en su teléfono inteligente, tableta o computadora.

Periódicamente, durante un año, recibirá un enlace a un cuestionario muy breve para completar.

Tarda menos de 30 segundos en completarse y puede responder a las preguntas en su teléfono inteligente, tableta o computadora. Inicialmente, recibirá el cuestionario todos los días. Con el tiempo puede recibirlo con menos frecuencia. El estudio continuará mientras existan inquietudes sobre la pandemia en nuestra región; sin embargo, usted puede dejar de recibir los cuestionarios en cualquier momento.

El cuestionario cubrirá lo siguiente:

  • Su historial o síntomas de la enfermedad de COVID-19
  • Sus visitas al médico y tratamientos
  • Su contacto con otras personas enfermas
  • Si usted es del personal de salud, información sobre el uso que haga de su equipo de protección personal

La información recopilada en el cuestionario se utilizará para fines de investigación y no se incluirá en sus registros médicos.

A algunos participantes también se les puede pedir que completen un kit de prueba en el hogar para detectar anticuerpos contra SARS-CoV-2 (el virus que causa el COVID-19). Usted puede decidir solo completar cuestionarios o puede agregar la prueba casera a su participación.

En esta parte, se le puede pedir que realice pruebas caseras mensuales que detecten anticuerpos contra el virus. La prueba casera requiere de un pinchazo para recolectar una muestra de su sangre en una barra de prueba. El kit le indicará que:

  • Tome una fotografía de la barra de prueba y envíela mediante una aplicación de su teléfono inteligente; o
  • Empaque la barra de prueba en uno de los sobres de devolución adjunto y envíelo atreves del servicio postal de los Estados Unidos.

La prueba casera no diagnostica COVID-19. Las pruebas se realizan únicamente con fines de investigación.

Las preguntas sobre este estudio de investigación pueden ser respondidas llamando al 800-808-5759 o enviando un correo electrónico a la Asociación de investigación comunitaria de COVID-19 a [email protected].

Empezar

Me gustaria inscribirme en este estudio.






COVID-19 Community Research Partnership

Thank you for your interest in learning more about this study. Please read the following information to learn more about the study and what you will be asked to do if you choose to participate. When you finish reading this information, there will be a link at the end on how to sign up for the study.

Researchers at MedStar Health are partnering with patients to better understand the spread of COVID-19 in our communities. Study participants will answer short online questions (that take less than 30 seconds a day) over the next year about possible exposure to the virus, symptoms, and health care visits. Some volunteers may be asked to complete an in-home test kit for antibodies to COVID-19.

This study is part of a nation-wide research project. You can find more frequently asked questions (FAQs) on the study website here.

Anyone in our community can take part in the study, whether or not you have received care at a MedStar Health clinic or Hospital.

.

I would like to participate in this study.

Join the Fight Against COVID-19 with MedStar Health!

Get answers to any questions you have about this research study by calling 800-808-5759 or emailing COVID-19 Community Research Partnership at [email protected].

Research studies are a way to gain scientific knowledge that may help people in the future.

Please take your time deciding whether or not you wish to participate in this research study. You may also discuss this study and your decision to participate with your friends and family. If you have questions about the study please call 800-808-5759 or email the COVID-19 Community Research Partnership at [email protected].

Anyone over the age of 18 can participate in this study. You do not need to have symptoms or COVID-19.

Yes! Anyone can take part in the study no matter where you live. If you are not a MedStar Health patient, we will not have access to your medical records, but we can still learn a lot from your participation. The information you share with us will be help us understand how our community as a whole is being affected by COVID-19.

No. If you are a MedStar Health patient, you can give us permission to access your medical records. Your medical records will remain confidential and be securely stored by the study team. Your information will be used only when mixed with other participant records. The study team will not be reviewing your individual records for this study.

If you are not a MedStar Health patient, we will not be able to link your data to your medical records. We will not contact your doctor or access your medical records in any way. But, we can still learn a lot from your participation. The information you share with us will still be valuable to help us understand how our community as a whole is being affected by COVID-19.

The information collected about you is for research purposes only. This information will not be used to guide your medical care. Your doctor or health care provider will not have access to this information. We will only be using your information in collection with other participants which will protect your privacy.

If you are eligible to participate, you will first read the informed consent and provide your electronic signature.

Informed consent is important because it:

  • Describes the study
  • Explains why the study is being done
  • Describes what is expected from you
  • Describes the risks and benefits of taking part
  • Explains how to contact the study team with questions

If you read the informed consent document and decide that you don’t want to participate in the study, that’s OK. Please do not sign the consent form if you don’t want to participate.

As you are aware, the COVID-19 pandemic is a global public health emergency.

By studying who has been exposed and possibly infected, better identifying the timing and circumstances of exposure, and where infection patterns of the COVID-19 are progressing, researchers can help the medical community better understand the pandemic and develop strategies and treatments to contain and possibly eliminate it.

The goal of this study is to collect information about the community’s COVID-19 exposures, symptoms, and health care visits due to the disease. If you are a health care worker, the study will collect information on your use of personal protective equipment.

There is no cost for participating.

The information collected about you is for research purposes only. This information will not be used to guide your medical care. Your doctor or health care provider will not have access to this information.

The research study cannot provide medical care or COVID-19 testing if you become sick. The questionnaires and at-home testing is for research purposes only. The daily symptom tracker and test results are not meant to diagnose or treat anyone for COVID-19.

After completion of the online informed consent, you will be asked to complete a brief enrollment questionnaire.

You will receive an email with a link to complete an online registration form. The form can be completed on your smartphone, tablet or computer.

Daily, for up to one year, you will receive a link to a very brief questionnaire to complete.

It takes less than 30 seconds to complete, and you can answer the questions on your smartphone, tablet or computer. Initially, you will receive the questionnaire every day. Over time you may receive it less often. The study will continue as long as there are concerns about the pandemic in our region; however, you can stop receiving the questionnaires at any time.

The questionnaire will cover the following:

  • Your COVID-19 illness history or symptoms
  • Your visits to the doctor and treatments
  • Your contact with other sick people
  • If you are a health care worker, your use of personal protective equipment

The information collected in the questionnaire will be used for research purposes and will not be entered into your medical records.

Some participants may also be asked to complete an in-home test kit for antibodies to SARS-CoV-2 (the virus that causes COVID-19). You can decide to only complete questionnaires or you can add the at-home testing to your participation.

For this part of the study you may be asked to complete monthly at-home tests which detect antibodies to the virus. At-home testing requires a finger prick for collecting a sample of your blood on a stick. Your kit will instruct you to either:

  • Take a picture of the test stick and send the picture using an app on your smart phone; or
  • Package the test stick in an enclosed return mailer and put into the US mail.

The at-home testing does not diagnose COVID-19. Testing is for research purposes only.

Questions on this research study can be answered by calling 800-808-5759 or emailing the COVID-19 Community Research Partnership at [email protected].

I would like to participate in this study.






Research Activities During COVID-19

The Office of Research Integrity has been actively supporting research teams regarding the possible need for changes to research activities during COVID-19.

MedStar Health Research Institute has been working with MedStar Health Corporate Compliance and the Georgetown HRPP team to develop joint guidance for the MedStar Health Research Institute, Georgetown University Medical Center, and Georgetown University Main Campus.

This guidance will require revision as conditions change. We will keep you informed of any updates to this guidance as they are available. 

As always, if you have any questions or concerns with this guidance, please contact ORI for clarification or additional guidance.

MHRI Office of Research Integrity
301-560-2912
[email protected]
Jim Boscoe
Director, Office of Research Integrity, MHRI
[email protected]
301-821-1530

Guidance for COVID-19’s Possible Effects on Research Involving Human Subjects (updated March 19, 2020)

In light of the unfolding COVID-19 pandemic, and in order to sustain our research activities as efficiently as possible, the following guidelines are issued jointly by the Medstar Health Research Institute, and the Georgetown University Medical Center and Main Campus, for the benefit of investigators and associated staff in both institutions. Specific questions relating to IRB practices and procedures should be directed to your home institution's IRB office.

The guidance/FAQ document can be viewed here.

 

Guidance for COVID-19 and Emergency Use (updated March 19, 2020)

We have a patient who tested positive for COVID-19 and want to pursue an Emergency Use of a Test Article. What do we do?  The guidance/FAQ document can be viewed here.

MedStar Health First to Join Innovative Cerner Network of Health Systems to Conduct Clinical Research

COLUMBIA, MD — MedStar Health is proud to announce it is a founding member and first health system to join the Cerner Learning Health NetworkSM, an innovative platform from Cerner Corporation (Nasdaq: CERN), a global health care technology company, designed to enhance clinical research and improve patient care through cross-industry collaboration.

The purpose of the Cerner Learning Health Network is to provide health systems and clinical research organizations with resources to more efficiently conduct medical studies that ultimately help advance health care for patients and clinicians. The network automates de-identified clinical data collection from participating members and pools it together in a database that health systems can access for approved clinical research. These health systems will have opportunities to participate in a variety of research studies, as well as propose their own research ideas. As part of the network, MedStar Health plans to bring trial opportunities to its clinical investigators and other members.

“We are proud to be one of the first health systems in this innovative approach to clinical research,” said Neil J. Weissman, MD, president of MedStar Health Research Institute and chief scientific officer for MedStar Health. “Using a network of academic health systems, linked with streamlined electronic data, will transform the efficiency and effectiveness of clinical trials.”

As a member of the network, MedStar Health has the opportunity to leverage the Cerner electronic health record and HealtheIntent® data and insights platform to support research. As Cerner continues to develop new tools and innovations to further advance research, MedStar Health and other members will be supported with these cutting-edge solutions while they utilize the network to conduct studies that can help solve some of health care’s biggest challenges.

“The Cerner Learning Health Network is a logical evolution of our 40 plus-year legacy of innovation and client service. It represents a novel approach to clinical research, helping our provider clients use data to obtain real-world evidence and evaluate the effectiveness of medical therapies and devices,” said Art Glasgow, senior vice president of Strategic Growth for Cerner. “Providers that join the network have the opportunity to be included in research and discovery efforts across the industry, access potential funding for studies and use advanced health IT solutions for analysis. Cerner’s breadth and scale offer a game-changing platform for clinical research.” 

A critical component of the Cerner Learning Health Network is maintaining data privacy protections. The network only supports access to de-identified data, which will not be permitted to leave Cerner’s monitored systems nor will it be shared without direct project-based consent. Under no circumstances will individually identifiable data leave the network without appropriate authorization of participating health systems. All uses of clinical data in the network will be overseen by a governance board so that data are only used for legitimate research purposes. The governance board will include patient representation, leading researchers and an ethicist to review all use cases. As one of the first members of this research network, MedStar Health will be a part of the governance board.

###

About MedStar Health Research Institute
The MedStar Health Research Institute is the research arm of MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region. MHRI provides scientific, administrative and regulatory support for research programs throughout the MedStar Health system. MHRI’s expertise includes translational research into disease prevention, diagnosis and treatment. These programs complement the key clinical services and teaching programs in the 10 MedStar hospitals and other MedStar entities. For more information, visit www.MedStarResearch.org 

About MedStar Health
At MedStar Health, we use the best of our minds and the best of our hearts to serve our patients, those who care for them, and our communities. Our 30,000 associates and 4,700 affiliated physicians are committed to living this promise through our core SPIRIT values—Service, Patient first, Integrity, Respect, Innovation, and Teamwork—across our more than 300 locations including 10 hospitals, ambulatory, and urgent care centers. As the medical education and clinical partner of Georgetown University, MedStar Health is training future physician leaders to care for the whole person and is advancing care through the MedStar Health Research Institute. From our telemedicine and urgent care services to the region’s largest home health agency, we’re committed to providing high-quality health care that’s also easy and convenient for our patients. At MedStar Health—It’s how we treat people. Learn more at MedStarHealth.org.

About Cerner
Cerner’s health technologies connect people and information systems at thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities. Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.com, The Cerner Blog, The Cerner Podcast or connect on Facebook, Instagram,  LinkedIn or  Twitter. Nasdaq: CERN. Smarter Care. Better Outcomes. Healthier You. 

Media Contact

Eva Hochberger
Communications & Planning Manager, MHRI
[email protected]

 

 

 





Diabetes to Go

Diabetes to Go

Overview

Diabetes self-management education and support (DSMES) is key to reducing the burden of diabetes both on those living with this chronic, complex condition and on the healthcare system.1 DSMES is defined as the ongoing process of facilitating the knowledge, skills, and ability necessary for diabetes self-care.2–4 Effective delivery and patient uptake of DSMES has been shown to improve outcomes, including reduction in hemoglobin A1C, diabetes-related complications 5,6 and acute care encounters,7 and to promote adoption of healthy lifestyle behaviors.3,8–10

Research confirms that DSMES is largely underutilized. For example, less than 5% of Medicare beneficiaries access their DSMES benefits,11 and as few as 7% of patients with private insurance receive DSMES within the one-year after diabetes diagnosis.12 Innovative approaches for reaching patients with T2DM and successfully engaging them in DSMES are required to optimize its potential impact.

Diabetes survival skills education (DSSE), a component of DSMES, is the process of facilitating the core knowledge, skills, and ability necessary for safe and effective diabetes self-care in the short term.14–16 The goal of DSSE is to keep patients safe and stable during transitions of care (e.g., from hospital to home) and for patients with T2DM to be able to recognize when their diabetes is not well managed (e.g., hypo or hyperglycemic events).

Approaches to effectively deliver standardized self-care management education and support for adults living with Type 2 diabetes (T2DM) are needed to enable optimal outcomes.

Diabetes To Go is the education program of the MedStar Diabetes Institute.

This program has been developed by our diabetes specialists, including Endocrinologists and nurses, nutritionists, nurse practitioners and pharmacist who are diabetes educators, in partnership with our Primary Care Physicians. Our patients and a health literacy specialist helped develop and reviewed the program.

The Diabetes To Go Booklet covers diabetes survival skills – or the basics about diabetes.

The Diabetes To Go Pocket Guide is a brief summary of the same content that is found in the booklet.

The Diabetes To Go program has a full set of companion videos.  A few samples of these videos are found below for viewing.

 


For Patients

Know About Your Diabetes: Full Guide

Survival Skills Basics Pocket Guide

 


Diabetes to Go Sample Videos

 

Application Process: Logic Chart for Video Playlists

 


For Staff & Clincians

Process Chart for Education Delivery

Tablet Cleaning Job Aid

Create a Patient Account

Script: Invite a Patient to Join in Education

Survival Skills Basics Pocket Guide

 


MedStar Diabetes and Research Institutes’ “Diabetes To Go-Inpatient Study” was funded by the National Institutes of Health-NIDDK R34 DK-105903 Award. This grant funded redesign of the MDI’s Diabetes To Go education materials .


References

  1. Powers MA, Bardsley J, Cypress M, et al. Diabetes Self-management Education and Support in Type 2 Diabetes. Diabetes Educ. 2017;43(1):40-53. doi:10.1177/0145721716689694
  2. Armstrong C. ADA Updates Standards of Medical Care for Patients with Diabetes Mellitus. Am Fam Physician. 2017;95(1):40-43. http://www.ncbi.nlm.nih.gov/pubmed/28075100. Accessed May 5, 2017.
  3. Powers MA, Bardsley J, Cypress M, et al. Diabetes Self-Management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. J Acad Nutr Diet. 2015;115(8):1323-1334. doi:10.1016/j.jand.2015.05.012
  4. Beck J, Greenwood DA, Blanton L, et al. 2017 National Standards for Diabetes Self-Management Education and Support. Diabetes Educ. 2017;43(10):1409-1419. doi:10.2337/dci17-0025
  5. Steinsbekk A, Rygg L, Lisulo M, Rise MB, Fretheim A. Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv Res. 2012;12(1):213. doi:10.1186/1472-6963-12-213
  6. Rise MB, Pellerud A, Rygg LØ, Steinsbekk A. Making and Maintaining Lifestyle Changes after Participating in Group Based Type 2 Diabetes Self- Management Educations: A Qualitative Study. PLoS One. 2013;8(5):e64009. doi:10.1371/journal.pone.0064009
  7. Healy SJ, Black D, Harris C, Lorenz A, Dungan KM. Inpatient diabetes education is associated with less frequent hospital readmission among patientswith poor glycemic control. Diabetes Care. 2013;36(10):2960-2967. doi:10.2337/dc13-0108
  8. Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns. 2016;99:926-943. doi:10.1016/j.pec.2015.11.003
  9. Magee M, Bowling A, Copeland J, Fokar A, Pasquale P, Youssef G. The ABCs of diabetes: diabetes self-management education program for African Americans affects A1C, lipid-lowering agent prescriptions, and emergency department visits. Diabetes Educ. 37(1):95-103. doi:10.1177/0145721710392246
  10. Gurková E, Čáp J, Žiaková K. Quality of life and treatment satisfaction in the context of diabetes self-management education. Int J Nurs Pract. 2009;15(2):91-98. doi:10.1111/j.1440-172X.2009.01733.x
  11. Strawbridge LM, Lloyd JT, Meadow A, Riley GF, Howell BL. One-Year Outcomes of Diabetes Self-Management Training Among Medicare Beneficiaries Newly Diagnosed With Diabetes. Med Care. 2017;55(4):391-397. doi:10.1097/MLR.0000000000000653
  12. Li R, Shrestha SS, Lipman R, et al. Diabetes self-management education and training among privately insured persons with newly diagnosed diabetes--United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2014;63(46):1045-1049. http://www.ncbi.nlm.nih.gov/pubmed/25412060. Accessed July 8, 2019.
  13. Ferguson S, Swan M, Smaldone A. Does Diabetes Self-management Education in Conjunction With Primary Care Improve Glycemic Control in Hispanic Patients? Diabetes Educ. 2015;41(4):472-484. doi:10.1177/0145721715584404
  14. Hardee SG, Osborne KC, Njuguna N, et al. Interdisciplinary diabetes care: A new model for inpatient diabetes education. Diabetes Spectr. 2015;28(4):276-282. doi:10.2337/diaspect.28.4.276
  15. Youssef G, Ip EH, Magee M, et al. Validity and Reliability of a (Brief) Diabetes “Survival Skills” Knowledge Test: KNOW Diabetes. Diabetes Educ. 2019;45(2):184-193. doi:10.1177/0145721719828064
  16. Lewis VR, Benda N, Nassar C, Magee MF. Successful Patient Diabetes Education in the Emergency Department. Diabetes Educ. 2015;41(3):343-350. doi:10.1177/0145721715577484

 

 

 

 

 

 

Registration Now Open for the 2019 MedStar Health Research Symposium

Registration is open for the seventh annual MedStar Health Research Symposium on Thursday, May 30, 2019, from 1:30 to 6:30 pm at the Bethesda North Marriott Hotel and Conference Center. 

Hosted by the MedStar Health Research Institute and MedStar Health Academic Affairs, the MedStar Health Research Symposium is open to all members of the research community interested in learning more about research at MedStar. The Symposium offers the opportunity to connect with researchers, residents, executive leaders, and collaborative partners from across the region and our system to build meaningful relationships to further advance the health of our community.

The Research Symposium features scientific poster presentations from investigators across the system and the spectrum of care, information on research support services offered by MedStar Health Research Institute and the opportunity to connect with residents and researchers dedicated to advancing health. 

Learn more and register at MedStarHealth.org/Symposium

Agenda

8:30 am – 12:15 pm

Colloquium for Educators in the Health Professions

Hosted by GUMC’s Center for Innovation and Leadership in Education (CENTILE), the Colloquium for Educators in the Health Professions Colloquium is an opportunity for those across the system focused on education to gather, share ideas, and learn together.

12:15 pm – 1:15 pm

Plenary Speaker and Lunch

Holly J. Humphrey, MD, MACP, President of the Josiah Macy Jr. Foundation

1:30 pm - 2:30 pm

Pre-Symposium Professional Development and Advancement Sessions 

These 60-minute optional workshops are offered before the Symposium and are intended to provide small group educational sessions hosted by experts from the MedStar Health & Georgetown University communities. Each session focuses on a specific academic topic and is open to all Symposium attendees. Seats will be reserved for those who pre-register for the event. Attendees who do not pre-register for a session or who register on-site may attend these sessions on a first-come, first-seated basis.

  • Giving Feedback in Clinical Learning Environments
    Robin Gross, MD, FCCP; Rahul Bhat, MD; Shimae Fitzgibbons, MD; Sarah Thornton, MD
  • GUMC Academic Appointments & Promotions Updates
    Elliott Crooke, PhD; Rebecca Evangelista, MD
  • Harnessing the Power of Medical Informatics to Enhance Scholarship
    Nawar Shara, PhD
  • How to Teach and Assess Medical Professionalism
    Ming-Jung Ho, MD, DPhil; Sean Whelton, MD;
    Megha Fitzpatrick, MD
  • Navigating the New Joint IRB
    Kate Cohen, JD; Kristen Katopol, MS, CIM
  • Opportunities to Cultivate Expertise in Educational Scholarship
    Priscilla Furth, PhD; Tamika Auguste, MD; Amy Burke, MD
  • Stats Fundamentals
    Stephen Fernandez, MS
  • Tips and Tricks for Funding Success
    Raj Ratwani, PhD; Angela Thomas, DrPh; Federico Asch, MD

In addition, at this time is also the GME Town Hall. Residents, fellows, and faculty members from clinical sites throughout the MedStar Health GME consortium are invited to join for an interactive system-wide town hall session.

3:00 pm - 4:00 pm

Resident & Fellow Oral Presentations

As part of the MedStar Health system-wide resident research day, residents and fellows with the top scoring abstracts are invited to give a short oral presentation on their research to attendees. These presentations allow residents and fellows to gain the experience of presenting their research and allow them to share their work with the larger MedStar Health & Georgetown University communities.

4:00 pm

Abstract Presentations & Moderated Poster Sessions

The main feature of the Research Symposium, the Grand Ballroom opens to showcase the peer-reviewed abstract presentations from across MedStar Health & Georgetown University. Ranging from health services research to critical care to orthopedics, all departments and entities are represented by established investigators, residents, and fellows. Also featured during this time is a moderated poster session for resident and fellow submissions.

5:15 pm

Main Stage Presentations & Keynote Address

Join leadership from MedStar Health and Georgetown University in the main ballroom to recognize the importance of research and collaboration in our community and present awards to investigators with top scoring poster submissions. The keynote speaker for this year is Holly J. Humphrey, MD, MACP, president of the Josiah Macy Jr. Foundation.

6:30 pm

Post-Symposium Gratitude Reception 

Hosted by MedStar Philanthropy, all are invited to attend an on-site reception directly following the Moderated Poster Presentations & Awards in the main ballroom. This will provide further networking with MedStar leaders, researchers, associates, grateful patients and donors to research.

 

Congratulations to the 2019 Summer Research Scholars at MedStar Health

Every year, MedStar Health awards scholarships to approximately 30 first-year Georgetown University medical students in order to pursue research during the summer. For seven weeks, each summer scholar works under the direction of a MedStar Health physician-investigator to conduct research in a specific area, with the opportunity to have some clinical exposure during their summer between their first and second years of medical school. These scholars are housed at various locations throughout the MedStar system and their experience culminates with a capstone presentation in the fall.

Congratulations to the Class of 2022 Scholarship Recipients. Best of luck with your research!

Frank S. Pellegrini, M.D. Scholars
Recipient Research Area Location Mentor(s)
Brett Habermehl Patient Safety MI2/MWHC Seth Krevat, MD/Angela Thomas, DrPH, MPH, MBA
Thomas Pacheco Quality Improvement MI2/MWHC/MGUH Raj Ratwani, PhD
Pines-Kleinman Mental & Behavioral Health Scholar
Recipient Research Area Location Mentor(s)
Tyler McGehee Psychiatry MGUH Matthew Biel, MD
MedStar Health Primary Care Scholarships at MedStar Franklin Square (MFSMC)
Recipient Research Area Location Mentor(s)
Harry Tsou Family Medicine MFSMC Nancy Barr, MD
Alex Zhao Family Medicine MFSMC Nancy Barr, MD
MedStar Health Scholarships in Baltimore, MD
Recipient Research Area Location Mentor(s)
Anthony Jourdan Asthma & Allergy MUMH Sudhir Sekhsaria, MD
Julia Hernandez Internal Medicine MGSH David Weisman, MD/Rosemarie Maraj, MD
Arvin Daneshmand Internal Medicine MUMH Ruchi Prasad, MD/Alex Yazaji, MD/Stephanie Detterline, MD
Joseph Bano Sports Medicine MUMH Andy Lincoln, ScD
William Rate Orthopaedic Surgery MUMH Jacob Wisbeck MD
Kunal Kirloskar Endocrinology MUMH Pamela Schroeder, MD
Christian Delgado Curtis Hand Center MUMH Avi Giladi, MD
Jai Won Jung Radiology MUMH Quang Nguyen, MD
MedStar Health Scholarships in Washington, DC
Recipient Research Area Location Mentor(s)
Erik DiGiacomo Pulmonary/Critical Care MGUH Daniel Jamieson, MD/Rajiv Sonti, MD
Robert Cragon Vascular Surgery MWHC Steven Abramowitz, MD
Nicholas Bader Surgical Oncology MGUH Waddah Al-Refaie, MD
Matthew Sweeney Surgical Oncology MGUH Waddah Al-Refaie, MD
Ben Hack ID, Hepatitis & HIV MWHC Dawn Fishbein, MD
Krissy Kent OB/Gyn, HIV & Pregnancy MWHC Rachel Scott, MD
Ciara Sanchez OB/Gyn, HIV & Pregnancy MWHC Rachel Scott, MD
Joseph Nealon General Surgery/Surgical Education MGUH Shimae Fitzgibbons, MD
Sarah Schumacher General Surgery/Surgical Education MGUH Shimae Fitzgibbons, MD
Annemarie Newark Acute Care Surgery/Surgical Critical Care MWHC Erin Hall, MD, MPH
Brandon Stryder Acute Care Surgery/Surgical Critical Care MWHC Erin Hall, MD, MPH
Taymour Hashemzadeh Emergency Medicine/Ethics MGUH/MWHC Norine McGrath, MD
Maria Cacciapuoti Emergency Medicine MWHC Maryann Amirshahi, MD
Emilie Melvin Human Factors Engineering MI2 Kristen Miller, DrPH, CPPS
Vikram Siberry Human Factors Engineering MI2/MHRI Deliya Wesley, PhD, MPH
Ehab Bahrun Burn Surgery MWHC Laura Johnson, MD
Lily Joseph Palliative Care MWHC Michael Pottash, MD
Kevin McGowan Surgical Critical Care MWHC Seife Yohannes, MD
MedStar Health Scholarships in Population Health
Recipient Research Area Location Mentor(s)
Brynley Dean Community Pediatrics MGUH Janine Rethy, MD
Adaah Sayyed Neurology & Multiple Sclerosis Center GUMC Carlo Tornatore, MD
Sara Torres Psychiatry MGUH Matthew Biel, MD
Heng Nhuong Emergency Medicine MWHC Munish Goyal, MD
MedStar Health Orthopedic Institute Scholarships
Recipient Research Area Location Mentor(s)
Kevin Berardino Orthopedic Surgery Orthopedic Institute Evan Argintar, MD
Nikita Deshpande Orthopedic Surgery Orthopedic Institute Evan Argintar, MD